ISDA has responded to the International Accounting Standards Board’s (IASB) proposal to amend IFRS 9 Financial Instruments to enable companies to measure certain prepayable financial assets with so-called negative compensation options. ISDA’s members are of the view that it is important this issue is dealt with urgently, given the IFRS 9 application date is in January 2018. In view of this timetable, our members believe it is important for the IASB to limit any amendments made to IFRS 9 and, more specifically, to matters necessary to address the issue that was submitted to the IFRS Interpretations Committee. They do not think it is appropriate for the IASB to add more interpretative guidance by means of additional basis of conclusions paragraphs into the literature, which could have unintended consequences for other financial instruments.
Documents (1) for ISDA Responds to the IASB’s ED/2017/3 Prepayment Features
Latest
Episode 59: Reducing Burdens
As she nears the end of her term as chair of the European Securities and Markets Authority, Verena Ross joins The Swap to discuss progress in simplifying and reducing the burden of EU financial regulation, including transaction reporting. Please view...
CDS Market Dynamics: Record 2025
Global credit default swap (CDS) market activity reached a record $41.8 trillion in 2025, surpassing the previous peak of $38.7 trillion in 2022. Index CDS drove the increase, accounting for 93.3% of total activity and reaching a record $39.0 trillion....
ISDA Letter to CFTC on Public Interest Determinations for Event Contracts
On July 27, ISDA submitted a letter to the U.S. Commodity Futures Trading Commission (CFTC) on the CFTC’s proposed rulemaking on public interest determinations for event contracts published in the Federal Register on June 12, 2026. ISDA emphasized the importance...
ISDA Letter to BCBS on RMA Models
On July 24, ISDA wrote to the Basel Committee on Banking Supervision (BCBS) to request guidance on how the proposed Risk Mitigation Accounting (RMA) model under International Financial Reporting Standard (IFRS) 9/IFRS 7 should be treated for prudential regulatory capital...